C. Steven Ernest

2.8k citations

41 papers · 2.1k indexed · 1 hit paper · h-index 22

Impact in

Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 1%
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research

Papers in

Cardiology and Cardiovascular Medicine 17
- Antiplatelet Therapy and Cardiovascular Diseases 17
Statistics and Probability 5
- Statistical Methods in Clinical Trials 5

Co-authors: Daniel E. Salazar Kenneth J. Winters Christopher D. Payne John T. Brandt Nazar Farid Stephen D. Hall David Jones Stephen J. Iturria
Journals: The Journal of Clinical Pharmacology (6 papers)Clinical Pharmacology & Therapeutics (3 papers)CPT Pharmacometrics & Systems Pharmacology (3 papers)Diabetic Medicine (2 papers)Current Medical Research and Opinion (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

C. Steven Ernest

41 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel 2007 · 553 citations

Peers

Countries citing papers authored by C. Steven Ernest

Since Specialization

Citations

This map shows the geographic impact of C. Steven Ernest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Steven Ernest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Steven Ernest more than expected).

Fields of papers citing papers by C. Steven Ernest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Steven Ernest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Steven Ernest. The network helps show where C. Steven Ernest may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Steven Ernest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Steven Ernest Line = papers co-authored together C. Steven Ernest links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease Alzheimer s & Dementia Translational Research & Clinical Interventions ·Ivelina Gueorguieva, Brian A. Willis, Laiyi Chua, Kay Hoong Chow, C. Steven Ernest, Jian Wang, Sergey Shcherbinin, John R. Sims, Emmanuel Chigutsa	2023	14
2	Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease Clinical Pharmacology & Therapeutics ·Ivelina Gueorguieva, Brian A. Willis, Laiyi Chua, Kay Hoong Chow, C. Steven Ernest, Sergey Shcherbinin, Paul Ardayfio, Garrett R. Mullins, John R. Sims	2023	46
3	Donanemab exposure‐efficacy relationship in patients with early symptomatic Alzheimer’s disease Alzheimer s & Dementia ·Ivelina Gueorguieva, Laiyi Chua, Kay Hoong Chow, C. Steven Ernest, Brian A. Willis, Sergey Shcherbinin, John R. Sims, Emmanuel Chigutsa	2023	1
4	Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model Journal of Pharmacokinetics and Pharmacodynamics ·C. Steven Ernest, Joakim Nyberg, Mats O. Karlsson, Andrew C. Hooker	2014	1
5	Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON‐TIMI 38 Substudy The Journal of Clinical Pharmacology ·Jeffrey S. Riesmeyer, Daniel E. Salazar, Govinda J. Weerakkody, Lan Ni, Rebecca E. Wrishko, C. Steven Ernest, Junxiang Luo, Ying G. Li, David S. Small, Shashank Rohatagi, William L. Macias	2011	41
6	Integrated Analysis of Pharmacokinetic Data Across Multiple Clinical Pharmacology Studies of Prasugrel, a New Thienopyridine Antiplatelet Agent The Journal of Clinical Pharmacology ·David S. Small, Ying G. Li, C. Steven Ernest, John H. April, Nagy A. Farid, Christopher D. Payne, Kenneth J. Winters, Shashank Rohatagi, Lan Ni	2010	29
7	Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38 The Journal of Clinical Pharmacology ·Rebecca E. Wrishko, C. Steven Ernest, David S. Small, Ying G. Li, Govinda J. Weerakkody, Jeffrey R. Riesmeyer, William L. Macias, Shashank Rohatagi, Daniel E. Salazar, Elliott M. Antman, Stephen D. Wiviott, Eugene Braunwald, Lan Ni	2009	66
8	Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease Journal of Clinical Pharmacy and Therapeutics ·D. S. Small, Rebecca E. Wrishko, C. Steven Ernest, Lan Ni, Kenneth J. Winters, Nazar Farid, Y. G. Li, John T. Brandt, Daniel E. Salazar, Anthony G. Borel, Keri A. Kles, Christopher D. Payne	2009	61
9	Effect of Age on the Pharmacokinetics and Pharmacodynamics of Prasugrel during Multiple Dosing Drugs & Aging ·David S. Small, Rebecca E. Wrishko, C. Steven Ernest, Lan Ni, Kenneth J. Winters, Nagy A. Farid, Ying G. Li, Daniel E. Salazar, Christopher D. Payne	2009	13
10	Pharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver disease Journal of Clinical Pharmacy and Therapeutics ·D. S. Small, Nazar Farid, Y. G. Li, C. Steven Ernest, Kenneth J. Winters, Daniel E. Salazar, Christopher D. Payne	2009	23
11	Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Nagy A. Farid, David S. Small, Christopher D. Payne, Joseph A. Jakubowski, John T. Brandt, Ying G. Li, C. Steven Ernest, Daniel E. Salazar, Christopher S. Konkoy, Kenneth J. Winters	2008	73
12	Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel Journal of Thrombosis and Haemostasis ·John T. Brandt, Sandra Close, Stephen J. Iturria, Christopher D. Payne, Nazar Farid, C. Steven Ernest, D. Richard Lachno, Daniel E. Salazar, Kenneth J. Winters Hit paper breakdown →	2007	553
13	Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel Journal of Cardiovascular Pharmacology ·Christopher D. Payne, Ying Grace Li, David S. Small, C. Steven Ernest, Nagy A. Farid, Joseph A. Jakubowski, John T. Brandt, Daniel E. Salazar, Kenneth J. Winters	2007	135
14	Prasugrel, a New Thienopyridine Antiplatelet Drug, Weakly Inhibits Cytochrome P450 2B6 in Humans The Journal of Clinical Pharmacology ·Nag A. Farid, C. Payne, C. Steven Ernest, Y. Grace Li, Kennet J. Winters, Danie E. Salazar, D. S. Small	2007	47
15	STOCHASTIC PREDICTION OF CYP3A-MEDIATED INHIBITION OF MIDAZOLAM CLEARANCE BY KETOCONAZOLE Drug Metabolism and Disposition ·Jenny Y. Chien, Aroonrut Lucksiri, C. Steven Ernest, J. Christopher Gorski, Steven Wrighton, Stephen D. Hall	2006	60
16	Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes Diabetic Medicine ·Helle Linnebjerg, Prajakti A. Kothare, Zachary Skrivanek, Amparo de la Peña, Matthew E. Atkins, C. Steven Ernest, Michael Trautmann	2006	39
17	Mechanism-Based Inactivation of CYP3A by HIV Protease Inhibitors Journal of Pharmacology and Experimental Therapeutics ·C. Steven Ernest, Stephen D. Hall, David Jones	2005	200
18	Inhaled micronized crystalline human insulin using a dry powder inhaler: dose‐response and time‐action profiles¹ Diabetic Medicine ·Klaus Rave, Leszek Nosek, Lutz Heinemann, Celedon Gonzales, C. Steven Ernest, Jenny Y. Chien, Douglas B. Muchmore	2004	24
19	Effect of Potent CYP2D6 Inhibition by Paroxetine on Atomoxetine Pharmacokinetics The Journal of Clinical Pharmacology ·Donna J. Belle, C. Steven Ernest, John‐Michael Sauer, Brian P. Smith, Holly R. Thomasson, Jennifer Witcher	2002	79
20	[Bilateral hypoplasia of the internal carotid with persistance of an admirable network. Apropos of a case in an adult]. PubMed ·C. Steven Ernest, Hirsch Jf, J Metzger, P Chahinian, Jean Pascal leBlanc, P Godeau	1973	3

About C. Steven Ernest

C. Steven Ernest is a scholar working on Cardiology and Cardiovascular Medicine, Statistics and Probability, Pharmacology, Pharmacology and Family Practice, having authored 41 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (17 papers), Lipoproteins and Cardiovascular Health (13 papers), Pharmacogenetics and Drug Metabolism (5 papers), Statistical Methods in Clinical Trials (5 papers), Inflammatory mediators and NSAID effects (5 papers), Diabetes Treatment and Management (4 papers), Analytical Methods in Pharmaceuticals (3 papers) and Alzheimer's disease research and treatments (3 papers). The work is most often cited by research in Internal Medicine (311 citations), Cardiology and Cardiovascular Medicine (1.4k citations), Pharmacology (328 citations), Endocrinology, Diabetes and Metabolism (452 citations) and Pharmacology (439 citations). C. Steven Ernest has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Daniel E. Salazar, Kenneth J. Winters, Christopher D. Payne, John T. Brandt, Nazar Farid, Stephen D. Hall, David Jones, Stephen J. Iturria, D. Richard Lachno and Sandra Close. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, CPT Pharmacometrics & Systems Pharmacology, Diabetic Medicine and Current Medical Research and Opinion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact